Innovating Works

TIME IS BRAIN SL

Activa
promise: BraiN20®: A paradigm shift in Acute Ischemic Stroke (AIS) patient management TIME IS BRAIN SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOROPEN-01 Acute Ischemic Stroke (AIS) represents 85% of strokes and is the 2nd leading cause of death and the leading cause of disability worldwide. T...
2023-04-05 - 2026-04-30 | Financiado
T_CELL(S)_DIFFER: Differentiation of pro inflammatory T cell subsets in vivo INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES tramitó un FP7: Our understanding of T cell differentiation impacts on vaccine development and on the treatment of (auto) immune disorders. T cells are key...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.